Public signalCompany raiseAuto-indexed · Unverified
Gliknik Inc raised $5.3M
Gliknik Inc· BALTIMORE, US· Biotechnology· Filed Jan 24, 2025
Gliknik Inc reported raising capital. Based in BALTIMORE, MARYLAND, US. First sale reported 2024-11-06. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$5.3M
Confidence90%
Raised
$5.3M
Investors
25
Jurisdiction
DELAWARE
On the record
- Location
- BALTIMORE, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $5.3M
- Target amount
- $6.0M
- Filing date
- Jan 24, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 25
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $6.0M
- Amendment
- Yes
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Charles Polsky
Director
Baltimore, US
David Broser
Director
Baltimore, US
David S. Block
Executive Officer
Baltimore, US
Elizabeth C. Block
Executive Officer
Baltimore, US
Kyle Rusconi
Director
Baltimore, US
Paul A. Friedman
Director
Baltimore, US
Raymond Schinazi
Director
Baltimore, US
Richard S. Levy
Director
Baltimore, US
Sources & provenance
“Operating company sold 5,286,743 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 24, 2025. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyBiotechnology$1M – $10MCompany Raise
Are you associated with Gliknik Inc?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record